Skip to main content

Table 2 Comparison of tumor characteristics between the PTC + SHPT and PTC groups

From: Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism

 

PTC + SHPT (n = 34)

PTC (n = 136)

p

Age* (years)

47 (30–69)

47 (30–69)

1.000

Male

15 (44.1%)

15 (44.1%)

1.000

Tumor diameter* (mm)

5.57 (0.5–15)

9.00 (0.5–40)

 < 0.001

Tumor diameter < 10 mm

29 (85.29%)

86 (63.24%)

0.014

Tumor bilaterality

9 (26.47%)

29 (21.32%)

0.499

Tumor multicentricity

15 (44.12%)

39 (28.68%)

0.066

Tumor extrathyroidal extension

2 (5.88%)

19 (13.97%)

0.255

Lymph node metastasis rate

12 (35.29%)

49 (36.03%)

1.000

  1. PTC papillary thyroid carcinoma, SHPT secondary hyperparathyroidism
  2. p < 0.05 was considered statistically significant
  3. *Average (min–max)